Information Provided By:
Fly News Breaks for March 18, 2019
BHC
Mar 18, 2019 | 06:32 EDT
Mizuho analyst Irina Koffler raised her price target for Bausch Health Companies to $41 from $39 following the company's Q4 results and a meeting with management. Most companies struggle to attain long-term guidance targets, but Bausch's 2019-2022 outlook is "within reach," Koffler tells investors in a research note. She reiterates a Buy rating on the shares.
News For BHC From the Last 2 Days
There are no results for your query BHC